日本人2型糖尿病患者におけるアルビグルチドと経口血糖降下薬単剤療法との併用による長期安全性および有効性を評価する研究

基本情報

NCT ID: NCT01777282
ステータス: 完了
試験のフェーズ: 第3相
試験タイプ: 介入
目標被験者数: 374
治験依頼者名: GlaxoSmithKline

概要

This study is designed to examine the long term safety and efficacy of weekly subcutaneously injected albiglutide in combination with a single oral antidiabetic drug for 52 weeks in Japanese subjects with type 2 diabetes mellitus.

対象疾患

Diabetes Mellitus

介入

Albiglutide(DRUG)

Sulfonylurea(DRUG)

Biguanide(DRUG)

Glinide(DRUG)

Thiazolidinedione(DRUG)

Alpha-glucosidase inhibitor(DRUG)

依頼者（Sponsor）

グラクソ・スミスクライン株式会社(INDUSTRY)

実施施設 (49)

GSK Investigational Site

Gunma, Japan

函館中央病院

Hokkaido, Japan

GSK Investigational Site

Fukuoka, Japan

GSK Investigational Site

Shizuoka, Japan

GSK Investigational Site

Osaka, Japan

GSK Investigational Site

Saitama, Japan

GSK Investigational Site

Hokkaido, Japan

GSK Investigational Site

Tokyo, Japan

GSK Investigational Site

Chiba, Japan

GSK Investigational Site

Miyagi, Japan

公立学校共済組合　九州中央病院

Fukuoka, Japan

医療法人　医仁会武田総合病院

Kyoto, Japan

GSK Investigational Site

Nagano, Japan

GSK Investigational Site

Osaka, Japan

GSK Investigational Site

Ōita, Japan

GSK Investigational Site

Kanagawa, Japan

GSK Investigational Site

Kumamoto, Japan

GSK Investigational Site

Saitama, Japan

GSK Investigational Site

Osaka, Japan

GSK Investigational Site

Ibaraki, Japan

GSK Investigational Site

Saitama, Japan

GSK Investigational Site

Gunma, Japan

GSK Investigational Site

Fukushima, Japan

GSK Investigational Site

Okinawa, Japan

GSK Investigational Site

Tokyo, Japan

GSK Investigational Site

Kochi, Japan

GSK Investigational Site

Fukuoka, Japan

GSK Investigational Site

Kanagawa, Japan

GSK Investigational Site

Fukushima, Japan

GSK Investigational Site

Saitama, Japan

GSK Investigational Site

Osaka, Japan

GSK Investigational Site

Miyagi, Japan

GSK Investigational Site

Tokyo, Japan

GSK Investigational Site

Osaka, Japan

一般財団法人積善会十全総合病院

Ehime, Japan

GSK Investigational Site

Saitama, Japan

GSK Investigational Site

Kyoto, Japan

GSK Investigational Site

Kanagawa, Japan

GSK Investigational Site

Kagoshima, Japan

GSK Investigational Site

Tochigi, Japan

GSK Investigational Site

Saitama, Japan

GSK Investigational Site

Aichi, Japan

GSK Investigational Site

Ibaraki, Japan

GSK Investigational Site

Tokyo, Japan

GSK Investigational Site

Kagawa, Japan

GSK Investigational Site

Nagano, Japan

GSK Investigational Site

Kumamoto, Japan

武田病院

Kyoto, Japan

GSK Investigational Site

Kanagawa, Japan